Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
- PMID: 28101605
- DOI: 10.1007/s00134-017-4683-6
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Abstract
Objective: To provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012".
Design: A consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development.
Methods: The panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable.
Results: The Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions.
Conclusions: Substantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.
Keywords: Evidence-based medicine; Grading of Recommendations Assessment, Development, and Evaluation criteria; Guidelines; Infection; Sepsis; Sepsis bundles; Sepsis syndrome; Septic shock; Surviving Sepsis Campaign.
Comment in
-
New Surviving Sepsis Campaign guidelines: back to the art of medicine.Eur Respir J. 2018 Jul 11;52(1):1701818. doi: 10.1183/13993003.01818-2017. Print 2018 Jul. Eur Respir J. 2018. PMID: 29997181 No abstract available.
Similar articles
-
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255. Crit Care Med. 2017. PMID: 28098591
-
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children.Pediatr Crit Care Med. 2020 Feb;21(2):e52-e106. doi: 10.1097/PCC.0000000000002198. Pediatr Crit Care Med. 2020. PMID: 32032273
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.Intensive Care Med. 2013 Feb;39(2):165-228. doi: 10.1007/s00134-012-2769-8. Epub 2013 Jan 30. Intensive Care Med. 2013. PMID: 23361625 Free PMC article.
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
-
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.Crit Care Med. 2008 Jan;36(1):296-327. doi: 10.1097/01.CCM.0000298158.12101.41. Crit Care Med. 2008. PMID: 18158437
Cited by
-
Deep reinforcement learning extracts the optimal sepsis treatment policy from treatment records.Commun Med (Lond). 2024 Nov 22;4(1):245. doi: 10.1038/s43856-024-00665-x. Commun Med (Lond). 2024. PMID: 39578542 Free PMC article.
-
Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae.Sci Rep. 2024 Nov 22;14(1):28992. doi: 10.1038/s41598-024-79924-9. Sci Rep. 2024. PMID: 39578508 Free PMC article.
-
The impact of ulinastatin on lymphocyte apoptosis and autophagy in sepsis patients.Sci Rep. 2024 Nov 20;14(1):28791. doi: 10.1038/s41598-024-79878-y. Sci Rep. 2024. PMID: 39567616 Free PMC article. Clinical Trial.
-
Exploring the value of hybrid capture-based next-generation sequencing technology in the suspected diagnosis of bloodstream infections.PeerJ. 2024 Nov 8;12:e18471. doi: 10.7717/peerj.18471. eCollection 2024. PeerJ. 2024. PMID: 39529632 Free PMC article.
-
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition.Int J Mol Sci. 2024 Oct 30;25(21):11662. doi: 10.3390/ijms252111662. Int J Mol Sci. 2024. PMID: 39519216 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

